– USA, NY – Marsh McLennan (NYSE: MMC), a global leader in risk, strategy, and people, announced the appointment of Bruce Broussard to its Board of Directors, effective immediately, bringing the Board to 12 members.
About Bruce Broussard
Bruce Broussard has over 30 years of experience leading public and private healthcare organizations. He was named President of Humana in 2011 and served as CEO from 2013 to 2024. Before that, he was CEO of McKesson Specialty/US Oncology. He joined US Oncology, which was acquired by McKesson Specialty, in 2000, and held various leadership roles, including CFO, President, CEO, O, and Chairman of the Board.
Bruce Broussard also serves on the boards of directors of HP Inc., the Cleveland Clinic, and One Call. Additionally, he holds leadership positions in numerous advocacy organizations, including The Business Council and the American Heart Association’s CEO Roundtable. He is also the Chair of the Board of Directors of the Trust for the National Mall, a nonprofit philanthropic partner of the National Park Service dedicated to restoring and preserving the National Mall.
About Marsh McLennan
Marsh McLennan is a global leader in risk, strategy, and people, advising clients in 130 countries across four businesses: Marsh, Guy Carpenter, Merc, er and Oliver Wyman. With annual revenue of over $24 billion and more than 90,000 colleagues, Marsh McLennan helps build the confidence to thrive through the power of perspective.
For more: https://www.marshmclennan.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.